Bruijn L I, Houseweart M K, Kato S, Anderson K L, Anderson S D, Ohama E, Reaume A G, Scott R W, Cleveland D W
Ludwig Institute for Cancer Research and Departments of Medicine and Neuroscience, University of California, La Jolla, CA 92093, USA.
Science. 1998 Sep 18;281(5384):1851-4. doi: 10.1126/science.281.5384.1851.
Analysis of transgenic mice expressing familial amyotrophic lateral sclerosis (ALS)-linked mutations in the enzyme superoxide dismutase (SOD1) have shown that motor neuron death arises from a mutant-mediated toxic property or properties. In testing the disease mechanism, both elimination and elevation of wild-type SOD1 were found to have no effect on mutant-mediated disease, which demonstrates that the use of SOD mimetics is unlikely to be an effective therapy and raises the question of whether toxicity arises from superoxide-mediated oxidative stress. Aggregates containing SOD1 were common to disease caused by different mutants, implying that coaggregation of an unidentified essential component or components or aberrant catalysis by misfolded mutants underlies a portion of mutant-mediated toxicity.
对在超氧化物歧化酶(SOD1)中表达与家族性肌萎缩侧索硬化症(ALS)相关突变的转基因小鼠的分析表明,运动神经元死亡源于突变介导的一种或多种毒性特性。在测试疾病机制时,发现野生型SOD1的消除和升高对突变介导的疾病均无影响,这表明使用SOD模拟物不太可能是一种有效的治疗方法,并提出了毒性是否源于超氧化物介导的氧化应激的问题。含有SOD1的聚集体在不同突变体引起的疾病中很常见,这意味着一种或多种未鉴定的必需成分的共聚集或错误折叠的突变体的异常催化是部分突变介导的毒性的基础。